Skip to main content

Table 1 Clinical indices and nocturia-related parameters in patients with BPH

From: The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study

Variable

Median (mean ± SD)

Number of patients

148

Age (years)

69.5 ± 5.6

LUTS/BPH duration (years)

6.3 ± 3.1

I-PSS

20.3 ± 5.0

Storage symptom score

11.7 ± 3.4

Voiding symptom score

8.6 ± 2.3

QoL score

3.7 ± 1.0

Nocturia score

3.0 ± 1.0

Serum PSA (ng/ml)

2.0 ± 1.7

Prostate volume (ml)

40.4 ± 19.4

NPi

0.43 ± 0.12

24-h drinking volume (ml)

1565.4 ± 624.8

4-h before bedtime drinking volume (ml)

123.9 ± 109.9

Frequency of nocturia

3.3 ± 1.1

Frequency of daytime urination

8.1 ± 2.6

Maximum urination volume (ml)

352.8 ± 119.3

Morning urine volume (ml)

260.5 ± 109.7

24-h total urine volume (ml)

1996.5 ± 637.5

Nocturnal urine volume (ml)

845.7 ± 339.0

  1. LUTS lower urinary tract symptoms, BPH benign prostatic hyperplasia, PSA prostate-specific antigen, I-PSS, international prostate symptom score, NPi nocturnal polyuria index, QoL quality of life